Exhibit 99.1

Contact:		Mark A. Kopser Executive Vice President and Chief Financial Officer (972) 713-3500

UNITED SURGICAL PARTNERS INTERNATIONAL
ANNOUNCES THIRD QUARTER 2011 RESULTS

Dallas, Texas (November 2, 2011) — United Surgical Partners International, Inc. (“USPI” or the “Company”) today announced results for the third quarter and nine months ended September 30, 2011.

Third Quarter Financial Results

     For the quarter ended September 30, 2011, consolidated net revenues increased 6% to $149.5 million compared with $141.4 million in the prior year period. Operating income increased 14% for the third quarter and was $56.6 million as compared with $49.6 million for the prior year period. Operating income margin for the third quarter increased 280 basis points to 37.9% versus 35.1% in the prior year period. Both the current and prior year had de novo start-up losses, acquisition related costs, and certain non-facility operating expenses, which are explained in more detail in our 10Q filing. Adjusted EBITDA less noncontrolling interests increased to $49.4 million versus $48.7 million in the prior year quarter.

     The financial results for the third quarter were driven by systemwide revenue growth of 12%, consisting of 6% U.S. same-facility revenue growth and the remainder being due to acquisition activity.

     Cash flows from operating activities for the third quarter totaled $67.7 million compared with $61.4 million for the prior year period. During the third quarter, the Company and its consolidated subsidiaries invested approximately $2.8 million in maintenance capital expenditures and an additional $9.3 million to develop new facilities and expand existing facilities.

Nine-Month Financial Results

     For the nine months ended September 30, 2011, consolidated net revenues increased 6% to $447.6 million compared with $422.5 million in the prior year period. Operating income increased 13% for the first nine months of 2011 to $178.1 million as compared with $157.5 million for the prior year period. Operating income margin for the first nine months of 2011 increased 250 basis points to 39.8% versus 37.3% in the prior year period. Both the current and prior year had de novo start-up losses, acquisition related costs, and certain non-facility operating expenses, which are explained in more detail in our 10Q filing. Adjusted EBITDA less noncontrolling interests increased to $151.4 million from $144.3 million in the prior year period.

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 2
November 2, 2011

     Cash flows from operating activities for the nine months ended September 30, 2011, totaled $140.4 million compared with $137.8 million for the prior year period. This increase was due to the Company’s 19% growth in net income being mostly offset by increased federal tax payments. The Company’s federal tax payments in the first half of 2010 were lower due to its still having significant net operating loss carryforwards to apply. During the first nine months of 2011, the Company and its consolidated subsidiaries invested approximately $11.9 million in maintenance capital expenditures and an additional $15.4 million to develop new facilities and expand existing facilities.

Systemwide Financial Results

     Due to the Company’s partnerships with physicians and not-for-profit healthcare systems, the Company does not consolidate the financial results of the majority of its facilities. While revenues of the Company’s unconsolidated facilities are not recorded as revenues by USPI, equity in earnings of unconsolidated affiliates is a significant and growing portion of the Company’s overall earnings. To help analyze results of operations, management uses systemwide operating measures such as systemwide revenue growth, which include revenues of both consolidated and unconsolidated facilities. In addition to overall systemwide revenue growth, USPI calculates growth rates and operating margins for the facilities that were operational in both the current and prior year periods, a group the Company refers to as same-store or same-facility. This group also consists of both consolidated and unconsolidated facilities. At September 30, 2011, 143 of the 204 facilities the Company operated were not consolidated.

Revenue Analysis

     For the third quarter, the systemwide revenues of the facilities operated by the Company increased 12% on a year-over-year basis, while consolidated revenues increased 6%. For the first nine months of 2011, the systemwide revenues of the facilities operated by the Company increased 13% on a year-over-year basis, while consolidated revenues increased 6%. The table below lists the key drivers of year-over-year changes in revenues.

		Three Months Ended								Nine Months Ended
		September 30, 2011								September 30, 2011
		As Reported				Unconsolidated				As Reported				Unconsolidated
		Under GAAP				Affiliates				Under GAAP				Affiliates
Total revenues, period ended September 30, 2010		$	141,392			$	329,882			$	422,454			$	951,420
Add: Revenue from acquired facilities			4,255				22,303				10,615				62,443
Less: Revenue of deconsolidated facilities			(3,411	)			3,411				(9,747	)			9,747
Less: Revenue of disposed facilities			—				(3,237	)			—				(6,628	)
Impact of exchange rate			936				—				3,896				—
Adjusted base period		$	143,172			$	352,359			$	427,218			$	1,016,982
Increase from operations			4,469				22,501				12,402				75,318
Non-facility based revenue			1,817				3,784				7,978				8,697
Total revenues, period ended September 30, 2011		$	149,458			$	378,644			$	447,598			$	1,100,997

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 3
November 2, 2011

Development Activity

     During the quarter, the Company acquired 14 facilities through the acquisition of Titan Health Corporation. Year-to-date, USPI has acquired 16 facilities, opened four de novo facilities, and sold its interest in five facilities.

Summary

     Commenting on the results, William H. Wilcox, USPI’s chief executive officer, said, “We continue to see pressure on organic volume growth due to overall weakness in the economy. However, we still believe that the fundamentals of the surgical business are sound and therefore continue to invest in acquisitions.”

     The live broadcast of USPI’s third quarter conference call will begin at 5:00 p.m. Eastern Time on November 2, 2011. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. A link to these events can be found on the Company’s website at www.uspi.com or at www.earnings.com. Additional financial information pertaining to United Surgical Partners International may be found by visiting the Investor Relations section of the Company’s website.

     USPI, headquartered in Dallas, Texas, currently has ownership interests in or operates 204 surgical facilities. Of the Company’s 199 domestic facilities, 138 are jointly owned with not-for-profit healthcare systems. The Company also operates five facilities in the United Kingdom.

     The above includes forward-looking statements based on current management expectations. Numerous factors exist that may cause results to differ from these expectations. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. These statements are subject to risks and uncertainties relating to the Company, including without limitation, (i) reduction in reimbursement from payors; (ii) the Company’s ability to attract physicians and retain qualified management and personnel; (iii) the Company’s significant leverage; (iv) geographic concentrations of certain of the Company’s operations; (v) risks associated with the Company’s acquisition and development strategies; (vi) the regulated nature of the healthcare industry; (vii) the highly competitive nature of the healthcare business; and (viii) those risks and uncertainties described from time to time in the Company’s filings with the Securities and Exchange Commission. Therefore, the Company’s actual results may differ materially. The Company undertakes no obligation to update any forward-looking statements or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 4
November 2, 2011

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Income
(in thousands, except number of facilities)

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2011				2010				2011				2010
Revenues		$	149,458			$	141,392			$	447,598			$	422,454
Equity in earnings of unconsolidated affiliates			18,684				17,247				56,718				49,754
Operating expenses:
Salaries, benefits and other employee costs			41,589				39,027				122,060				113,707
Medical services and supplies			24,680				23,571				73,857				71,878
Other operating expenses			24,694				27,568				72,405				72,847
General and administrative expenses			11,807				9,626				32,700				27,295
Provision for doubtful accounts			2,845				1,964				6,878				6,271
Net (gain) loss on deconsolidations, disposals and impairments			(1,271	)			(57	)			(3,749	)			536
Depreciation and amortization			7,169				7,342				22,042				22,128
Total operating expenses			111,513				109,041				326,193				314,662
Operating income			56,629				49,598				178,123				157,546
Interest expense, net			(15,507	)			(16,994	)			(49,284	)			(52,016	)
Other, net			5				367				(114	)			723
Income from continuing operations before income taxes			41,127				32,971				128,725				106,253
Income tax expense			(9,253	)			(7,095	)			(29,821	)			(24,238	)
Income from continuing operations			31,874				25,876				98,904				82,015
Discontinued operations, net of tax			10				281				(519	)			810
Net income			31,884				26,157				98,385				82,825
Less: Net income attributable to noncontrolling interests			(16,598	)			(14,309	)			(49,592	)			(43,079	)
Net income attributable to USPI’s common stockholder		$	15,286			$	11,848			$	48,793			$	39,746
Supplemental Data:
Facilities operated at period end			204				174				204				174

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 5
November 2, 2011

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
Unaudited Condensed Consolidated Balance Sheets
(in thousands)

		Sept. 30,				Dec. 31,
		2011				2010
ASSETS
Current assets:
Cash and cash equivalents		$	55,926			$	60,253
Accounts receivable, net of allowance for doubtful accounts of $7,908 and $7,481, respectively			48,336				50,082
Other receivables			15,177				15,242
Inventories			8,778				9,191
Deferred tax assets, net			11,050				14,961
Other			22,239				14,682
Total current assets			161,506				164,411
Property and equipment, net			203,132				202,260
Investments in unconsolidated affiliates			419,313				393,561
Goodwill and intangible assets, net			1,616,183				1,587,877
Other			21,436				24,630
Total assets		$	2,421,570			$	2,372,739
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable		$	24,887			$	23,488
Accrued expenses and other			224,896				218,786
Current portion of long-term debt			23,840				22,386
Total current liabilities			273,623				264,660
Long-term debt			1,018,207				1,047,440
Other liabilities			168,482				157,820
Total liabilities			1,460,312				1,469,920
Noncontrolling interests — redeemable			98,838				81,668
USPI stockholder’s equity			827,752				786,757
Noncontrolling interests — nonredeemable			34,668				34,394
Total equity			862,420				821,151
Total liabilities and equity		$	2,421,570			$	2,372,739

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 6
November 2, 2011

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
Key Operating Statistics
(in thousands, except for number of facilities, cases and percentages)

		Three Months Ended September 30,
		2011				2010				% Change
Systemwide same-facility statistics(1) (2):
United States:
Facility cases			208,911				209,324				(0.2	)%
Net revenue/case		$	2,260			$	2,132				6.0	%
Net revenue (in thousands)		$	472,075			$	446,253				5.8	%
Facility operating income margin(3)			26.7	%			26.3	%		40 bps
United Kingdom:
Adjusted admissions			5,218				5,226				(0.2	)%
Net revenue/adjusted admission		$	5,185			$	4,787				8.3	%
Net revenue/adjusted admission (at constant currency translation rates)(4)		$	5,185			$	4,967				4.4	%
Net revenue (in thousands)		$	27,056			$	25,016				8.2	%
Facility operating income margin(3)			16.9	%			21.7	%		(480) bps
Other:
Total consolidated facilities			61				60
EBITDA less noncontrolling interests(5)
GAAP operating income		$	56,629			$	49,598				14.2	%
Depreciation and amortization			7,169				7,342
Net (gain) loss on deconsolidations, disposals and impairments			(1,271	)			(57	)
EBITDA			62,527				56,883
Net income attributable to noncontrolling interests			(16,598	)			(14,309	)
EBITDA less noncontrolling interests		$	45,929			$	42,574				7.9	%
De novo start-up losses			1,817				133
Titan acquisition costs			1,611				—
Expense related to previous acquisitions			—				6,000
Adjusted EBITDA		$	49,357			$	48,707				1.3	%

-MORE-

United Surgical Partners Announces Third Quarter 2011 Results
Page 7
November 2, 2011

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
Key Operating Statistics (Continued)
(in thousands, except for number of facilities, cases and percentages)

		Nine Months Ended September 30,
		2011				2010				% Change
EBITDA less noncontrolling interests(5)
GAAP operating income		$	178,123			$	157,546				13.1	%
Depreciation and amortization			22,042				22,128
Net (gain) loss on deconsolidations, disposals and impairments			(3,749	)			536
EBITDA			196,416				180,210
Net income attributable to noncontrolling interests			(49,592	)			(43,079	)
EBITDA less noncontrolling interests		$	146,824			$	137,131				7.1	%
De novo start-up losses			2,889				147
Titan acquisition costs			1,734				—
Expense related to prior acquisition			—				6,000
VAT assessment			—				1,000
Adjusted EBITDA		$	151,447			$	144,278				5.0	%

-END-